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A Cohort Study of Vitamin D Intake and Melanoma
Risk
Maryam M. Asgari1,2, Sonia S. Maruti3,4, Lawrence H. Kushi1 and Emily White3,4
Data suggest that vitamin D intake may have chemopreventive efficacy against melanoma, but there have been
no published epidemiologic studies examining the association between vitamin D intake and melanoma risk in
a large prospective cohort. We examined whether dietary and supplemental vitamin D intake was associated
with melanoma risk among 68,611 men and women who were participants of the Vitamins and Lifestyle cohort
study. Participants reported dietary vitamin D intake over the past year and 10-year use of multivitamin and
individual vitamin D supplements on a baseline questionnaire. After follow-up through 2006, 455 incident
melanomas were identified through linkage to the Surveillance, Epidemiology, and End Results cancer registry.
Cox proportional hazards regression models were used to estimate relative risks (RRs) and 95% confidence
intervals (CIs) for vitamin D intake after adjustment for melanoma risk factors. Compared with the lowest
quartile, we did not detect a risk reduction of melanoma in the highest quartiles of dietary vitamin D intake
(RR¼ 1.31, CI¼ 0.94–1.82), 10-year average supplemental vitamin D intake (RR¼ 1.13, CI¼ 0.89–1.43), or combined
dietary and supplemental intake (1.05, CI¼ 0.79–1.40). In this large prospective cohort, we did not find an
association between vitamin D intake and melanoma risk.
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INTRODUCTION
Melanoma is the sixth most common cancer in the United
States (American Cancer Society Fact and Figures, 2007) and
its lifetime incidence is rising. It is estimated that one out of
every 55 Americans born in 2008 will be diagnosed with
melanoma during their lifetime (Ries et al., 2007). The rising
incidence of melanoma and its poor prognosis in advanced
stages (Gandini et al., 2005a, b) are compelling reasons to
identify novel chemopreventative agents. There is accumu-
lating evidence that the vitamin D pathway may play a
chemoprotective role in melanoma (Osborne and Hutch-
inson, 2002). The antiproliferative and prodifferentiation
effects of vitamin D and its metabolites have been demon-
strated in some melanoma cell lines in vitro (Colston et al.,
1981; Evans et al., 1996; Seifert et al., 2004; Reichrath et al.,
2007). In vivo, vitamin D suppresses growth in human
melanoma-derived xenografts in immunosuppressed mice
(Eisman et al., 1987) and inhibits melanoma migration,
invasion, and metastasis in mice inoculated with vitamin
D-treated melanoma cells (Yudoh et al., 1999). Epidemiolo-
gic studies of the association of vitamin D and melanoma risk
have shown conflicting results (Veierød et al., 1997; Millen
et al., 2004; Nu¨rnberg et al., 2008). We conducted a
prospective study of the Vitamins and Lifestyle (VITAL)
cohort to investigate whether vitamin D intake is associated
with melanoma risk.
RESULTS
The average age of participants was 62 years (range, 50–76
years), and slightly more than half of the participants were
female (52%). Most individuals had some college or an
advanced degree (80%) and were overweight or obese (63%).
Those with higher intakes of total vitamin D were more likely
to have some college education, family history of melanoma,
personal history of nonmelanoma skin cancer, history of
having had a mole removed, history of severe sunburns, and
higher total physical activity (Table 1). The majority of cohort
participants (64%) regularly took a multivitamin and 14%
used individual vitamin D supplements over the 10-year
period before baseline. The highest sources of dietary vitamin
D were dairy and fish products. Specifically, the top five
contributors to vitamin D intake were (1) nonfat or skim milk
(beverage), (2) dark fish (salmon), (3) white fish (sole, halibut),
(4) eggs, and (5) 2% milk.
Through linkage with SEER (Surveillance, Epidemiology,
and End Results) between October 2000 and December
2006, we identified 455 incident cases of cutaneous
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melanoma based on the coding of the International Classi-
fication of Diseases for Oncology-O-2. These included
melanoma in situ (n¼ 200), malignant melanoma NOS
(n¼120), superficial spreading melanoma (n¼ 70), lentigo
maligna melanoma (n¼ 33), nodular melanoma (n¼ 20), and
other subtypes including melanoma within a junctional nevus
(n¼5), spindle cell melanoma (n¼ 4), acral lentiginous
melanoma (n¼2), and desmoplastic melanoma (n¼1). The
majority of tumors (67%) were located on the trunk (n¼127)
and extremities (n¼179), whereas 31% (n¼ 139) of tumors
were located on the head and neck and 2% were not
otherwise specified.
There was no clear trend of melanoma risk with the
duration of use, dose per day or 10-year average intake of
supplemental vitamin D from multivitamins and individual
supplements (Table 2). There was a suggestion of a decreased
risk of melanoma among the high-dose supplement users
[X15 mcg/day 10-year average, adjusted relative risk
(RR)¼ 0.77, 95% confidence interval (CI)¼ 0.34–1.72],
although the test for trend was not significant (P¼0.67).
There was some evidence of an increased risk of melanoma
associated with increased dietary vitamin D intake (adjusted
RRs across quartiles: 1.0, 1.09, 1.41, 1.31; P for trend¼ 0.05).
There was no association between total intake of vitamin D
from diet plus supplements and melanoma risk. The
association between total vitamin D and melanoma did
not change with further adjustment for physical activity
(none, tertiles of MET-hour/week), body mass index (o24,
25–30 and 430 kgm2), and multivitamin use (never,
current, past).
We used both tumor subtype and tumor location variables
as proxies for patterns of sun exposure and explored their
association with vitamin D intake. Lentigo maligna and
lentigo maligna melanoma are associated with chronic sun
exposure, whereas superficial spreading melanoma is asso-
ciated with intermittent exposure (Elwood et al., 1987; Weiss
et al., 1991). Likewise, tumors of the head and neck are
reportedly associated with chronic patterns of sun exposure,
whereas trunk melanomas are associated with intermittent
patterns of sun exposure (Hoersch et al., 2006; Whiteman
et al., 2006). We explored the association between tumor
subtype (lentigo maligna versus other and superficial spread-
ing versus other) and total vitamin D intake and found no
significant association (P for difference 0.19 and 0.16,
respectively, data not shown). Nor was there a significant
difference of total vitamin D intake with respect to tumor
location (head and neck versus other: adjusted RRs across
quartiles: 1.0, 1.17, 1.02, 0.99; P for difference 0.77).
We also examined the effects of vitamin D on progression
of melanoma by examining invasion (in situ versus invasive)
and Breslow depth of the tumor in relation to total vitamin D
intake. There were 200 patients with in situ melanoma and
254 with invasive (including local, regional, and distant)
melanoma. The association between total vitamin D intake
and the risk of in situmelanoma was not appreciably different
than that and the risk of invasive melanoma (P for difference
Table 1. Association between participant’s characteristics and total vitamin D intake, VITAL cohort (2000–2006)1,2
Quartiles of total vitamin D intake
Q1 Q2 Q3 Q4
Total vitamin D intake (mean in mcg/day, range) 3.3 (0.0–5.1) 7.1 (45.1–9.5) 12 (49.5–14) 17 (414–58)
Sociodemographic factors3
Age at baseline (years) 62 62 62 62
Male (%) 49 54 47 52
Some college (%) 75 81 81 83
Melanoma risk factors3
1st degree family history melanoma (%) 5.8 6.0 6.2 6.3
Personal history of nonmelanoma skin cancer (%) 7.1 7.3 8.0 8.5
Ever had moles removed (%) 24 26 28 29
Had freckles between ages 10 and 20 years (%) 20 20 21 21
Had X3 severe sunburns between ages 10 and 20 years (%) 31 32 33 34
Natural red/blond hair between ages 10 and 20 years (%) 31 32 32 32
Reaction to 1-h in strong sunlight (%) 82 85 85 85
Lifestyle characteristics3
Height (in) 68 68 68 68
BMI at baseline (kgm2) 28 28 27 27
Total physical activity (MET-h/wk) 9 10 11 13
1Total vitamin D intake was calculated as the sum of mcg/day from diet over year before baseline plus 10 year-average mcg/day from all supplements.
2Age adjusted means or percentages of baseline characteristics were calculated by standardizing to the age distribution of the study population.
3Less than 1% missing data, except for BMI (3.5% missing).
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0.58, data not shown). Breslow depth was available for 230
cases. Among cases, linear regression adjusting for melanoma
risk factors was performed with total vitamin D intake, the
exposure, divided into quartiles and tumor thickness, the
continuous outcome, log transformed to more closely
approximate a normal distribution. There was no significant
association between vitamin D intake and tumor thickness (P
for trend¼0.20).
The association between total vitamin D intake and
melanoma risk did not differ by sex. The RRs among men
Table 2. Association between intakes of vitamin D and incident melanoma, VITAL cohort from 2000–2006
Vitamin D Sources Cohort N (%) Cases N (%) Age- and Sex-adjusted RR (95% CI) Multivariate adjusted RR (95% CI)1
10-year use of individual supplements
Overall use
None 58,609 (86) 389 (86) 1.00 1.00
Former/current 9,257 (14) 61 (14) 1.12 (0.85–1.47) 1.08 (0.82–1.43)
Duration (years)
None 58,609 (87) 389 (87) 1.00 1.00
1–3 3,519 (5) 26 (6) 1.31 (0.88–1.96) 1.26 (0.84–1.88)
4–6 2,028 (3) 18 (4) 1.53 (0.95–2.46) 1.49 (0.93–2.40)
47 3,286 (5) 13 (3) 0.64 (0.37–1.11) 0.62 (0.36–1.08)
P for trend2 0.61
Mcg/day on days taken
None 58,609 (89) 389 (90) 1.00 1.00
10 6,159 (9) 38 (9) 1.03 (0.74–1.45) 1.00 (0.71–1.40)
X15 1,295 (2) 6 (1) 0.79 (0.35–1.77) 0.77 (0.34–1.72)
P for trend2 0.67
10-year average mcg/day from individual and multivitamin supplements
None 21,608 (32) 138 (31) 1.00 1.00
40.0–3.9 11,675 (17) 73 (16) 1.10 (0.82–1.46) 1.05 (0.79–1.39)
43.9–9.9 15,176 (22) 96 (21) 1.09 (0.84–1.41) 1.03 (0.79–1.33)
49.9–30 19,398 (29) 143 (32) 1.21 (0.96–1.54) 1.13 (0.89–1.43)
P for trend2 0.36
Mcg/day from diet3
0.0–3.0 15,532 (25) 77 (18) 1.00 1.00
43.0–4.7 15,775 (25) 93 (22) 1.11 (0.82–1.52) 1.09 (0.80–1.48)
44.7–7.1 15,979 (25) 130 (31) 1.48 (1.09–1.99) 1.41 (1.04–1.90)
47.1–53 16,060 (25) 120 (29) 1.36 (0.98–1.88) 1.31 (0.94–1.82)
P for trend2 0.05
Mcg/day of total vitamin D4
0.0–5.1 15,878 (24) 99 (22) 1.00 1.00
45.1–9.5 16,503 (25) 103 (23) 0.95 (0.71–1.27) 0.91 (0.68–1.22)
49.5–14 16,487 (25) 113 (26) 1.04 (0.78–1.39) 0.97 (0.73–1.30)
414–58 16,705 (25) 126 (29) 1.14 (0.86–1.52) 1.05 (0.79–1.40
P for trend2 0.56
1Adjusted for: age at baseline (years), gender (female, male), education (high school or less, some college, advanced degree), 1st degree family history
melanoma (no, yes), personal history of nonmelanoma skin cancer (no, yes), ever had moles removed (no, yes), freckles between ages 10 and 20 years (no,
yes), hadX3 severe sunburns between ages 10 and 20 years (no, yes), natural red/blond hair between ages 10 and 20 years (no, yes), and reaction to 1-h in
strong sunlight (tan or no sunburn, mild burning, painful sunburn, severe sunburn with blistering). Dietary and total intakes of vitamin D were adjusted for
total energy intake (kcal/day).
2P for trend calculated by modeling categories of total vitamin D as a single ordinal variable in a Cox regression; a Wald test was used to obtain a P value.
3Mcg/day from diet over year before baseline.
4Total (diet plus supplemental) vitamin D intake was calculated as the sum of mcg/day from diet over year before baseline plus 10 year-average mcg/day
from all supplements.
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(adjusted RR¼0.97 for quartile 4 versus quartile 1; 95%
CI¼0.73–1.29) and women (adjusted RR¼ 1.10 for quartile 4
versus quartile 1; 95% CI¼ 0.70–1.73) were similar, and the
test for interaction was not significant (P¼ 0.51).
DISCUSSION
In this prospective study, we found no evidence to support an
inverse association between total intake of vitamin D and
melanoma risk. There was a suggestion that higher levels of
vitamin D intake from foods may be associated with
increased risk of melanoma (P trend across 4 quartiles
0.05), but the effect was inconsistent and was no longer
statistically significant when intake from foods and supple-
ments were combined. Among cases, we used two variables
as proxies for sun exposure patterns: tumor subtype and
tumor location, and found no relation in adjusted models
between either variables and total vitamin D intake. We also
did not detect an association between total vitamin D intake
and tumor invasion or Breslow depth. Adjustment for
melanoma risk factors did not alter these findings.
Our results differ from those of a large case–control
study of 503 melanoma patients and 565 controls (Millen
et al., 2004), which found a reduced risk of melanoma with
dietary vitamin D intake. However, the association with
vitamin D intake in that study was no longer significant
when vitamin D from dietary and supplemental sources
were combined. As with many case–control studies, exposure
data in that study were collected after case diagnosis,
making this study potentially vulnerable to recall bias
(Austin et al., 1994). Selection bias in case–control studies
is also a concern.
Other epidemiologic studies that have examined the
association of vitamin D with melanoma risk are consistent
with the generally null findings from our study. For example,
a smaller case–control study of 165 melanoma patients and
209 controls (Weinstock et al., 1992), found no association
between melanoma risk and total vitamin D intake, vitamin
D intake from foods or from supplements. Two studies
examining serum levels of vitamin D in melanoma patients
compared with controls were similarly null, whether the
levels were measured prediagnostically (Cornwell et al.,
1992) or at the time of diagnosis (Nu¨rnberg et al., 2008). The
only other published prospective study of potential relevance
to vitamin D intake and melanoma risk reported that cod-
liver oil consumption was associated with an increased risk of
melanoma among women but not among men (Veierød et al.,
1997). Cod-liver oil is known to be a concentrated source of
dietary vitamin D (400–1,000 International Unit/tsp). This
study followed 50,757 Norwegian men and women over an
average of 12.4 years and assessed frequency and types of
food, but the published paper did not comment specifically
on vitamin D intake. This observation related to cod-liver oil
may not be ascribable to a vitamin D specifically, as cod-liver
oil has other relatively unique nutritional characteristics, such
as its high concentration of n-3 fatty acids. This increased risk
is consistent, however, with our observations of a possible
increased risk of melanoma due to vitamin D intake
from foods.
Compared with the few previous epidemiologic studies on
this topic, strengths of this investigation include the avail-
ability of baseline information on major potential confound-
ing factors including constitutional, personal, and family skin
cancer history, and the prospective collection of information
thereby avoiding recall bias. Other advantages include the
relatively large number of melanoma cases and the high
percentage of supplement users recruited into this study. In
addition, we examined a long-term measure (up to 10 years)
of supplemental vitamin D use, which may be more
etiologically relevant to melanoma development. The high
test–retest reliability and validity of the VITAL questionnaire
in capturing supplement intake over the past 10 years has
been documented previously (Satia-Abouta et al., 2003).
There are several limitations to this study. We did not
measure serum vitamin D levels. Studies suggest that vitamin
D intake correlates with serum 25-hydroxy vitamin D levels
(Lips et al., 1987; Jacques et al., 1997; Sullivan et al., 2005),
especially in northern latitudes, where the influence of solar
radiation on vitamin D status is diminished (Sullivan et al.,
2005). In fact, some experts state that estimates of long-term
dietary and supplemental vitamin D intake and long-term sun
exposure may be the most logically feasible indicators of
lifetime vitamin D status in population-based studies (Millen
and Bodnar, 2008).
Also, this study did not ascertain detailed information on
some known melanoma risk factors such as number of nevi.
Adjusting for other melanoma risk factors did not alter the
risks in the multivariable model, thus, it is unlikely that
including the residual risk factors for melanoma would
appreciably change the results.
Sun exposure could have been a potential confounding
variable. The role of sun exposure is melanoma carcinogen-
esis is complex and differs for intermittent versus chronic
exposure (Gruber and Armstrong, 2006). We examined
proxies for intermittent versus chronic sun exposure among
cases and found no significant association with total vitamin
D intake. Western Washington State is also a region of low
sun exposure (latitude 471N). A previous study of vitamin D
levels at a similar northern latitude in the United States
(Bangor, ME, latitude 441N) showed only 28% change in
serum 25-hydroxy vitamin D levels between fall and spring,
suggesting that sunlight is not as strong a contributor to
vitamin D levels in Northern latitudes (Sullivan et al., 2005).
In our cohort, supplemental vitamin D was derived mostly
from multivitamins, as most participants (86%) did not use
individual vitamin D supplements. Only 2% of the cohort
had supplemental vitamin D intake corresponding to a
10-year daily average X600 International Unit (15mcg).
Therefore, we had limited ability to examine associations of
melanoma risk with high-dose supplemental vitamin D use.
Finally, our cohort preferentially recruited supplement users,
and the cohort had certain characteristics, such as high level
of education, that may limit the generalizability of the
findings.
In summary, our data, which are based on a large
prospective cohort, suggest no association between total
vitamin D intake from diet and supplements and melanoma
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risk. Future studies that measure serum vitamin D levels and
sun exposure should help further elucidate the association
between vitamin D and melanoma risk.
MATERIALS AND METHODS
Study population
Participants were 37,382 men and 40,337 women aged 50–76 years
residing in western Washington recruited in the VITAL study
between 2000 and 2002. The goal of VITAL was to investigate the
association between dietary supplement use and cancer risk.
Participants answered a 24-page self-administered questionnaire
about lifestyle factors, health history, dietary intake, supplement use,
personal characteristics, and cancer risk factors. Further details
regarding study design, recruitment, and study implementation have
been published previously (White et al., 2004). This study was
approved by the Fred Hutchinson Cancer Research Center Institu-
tional Review Board. The Declaration of Helsinki protocols were
followed and patients gave their written informed consent.
Exclusions
Participants were excluded if they reported a melanoma diagnosis at
baseline (n¼ 1,557). Nonwhites and those who did not report their
race were excluded from the analysis (n¼ 6,491). We also excluded
participants with preexisting conditions that could alter the vitamin
D synthesis pathway, including a history of cirrhosis of liver
(n¼ 172), chronic liver disease (n¼ 210), or history of kidney
disease (n¼ 678), leaving 68,611 participants.
Vitamin D
Dietary sources. A food frequency questionnaire was used to
ascertain dietary vitamin D intake, as well as other relevant nutrient
intakes. On the food frequency questionnaire, participants reported
their usual frequency and portion size of 120 foods or food groups
and beverages consumed during the year before baseline. This food
frequency questionnaire was adapted from those developed for the
Women’s Health Initiative and other studies (Kristal et al., 1997;
Patterson et al., 1999). Responses were converted into nutrient
intake using the Minnesota Nutrient Data System for Research
(Schakel et al., 1997).
Supplements. Participants reported intake of multivitamins and
vitamin supplements, taken singly or as mixtures over the 10 years
before baseline. For all supplement questions, a close-ended format
was used to inquire about current/past use, frequency, duration over
the previous 10 years, and usual dose per day for individual
supplements and brand or exact nutrient formulation for multi-
vitamins. Vitamin D is most commonly found in supplements as
cholecalciferol; therefore, International Units of supplemental
vitamin D were converted to mcg cholecalciferol by multiplying
by 0.025. Ten-year average daily supplemental intake of vitamin D
from multivitamins and individual supplements was calculated by
summing intakes from multivitamin preparations and individual
vitamin sources and was computed as:
P
(dose per day) (days per
week/7) (years/10).
Total intake (dietary and supplement). Total intake was
calculated by adding mcg/day from dietary sources with the
computed average intake in mcg/day over 10 years from multi-
vitamin and individual supplement sources.
Covariates
Other information considered in this analysis included established
risk factors for melanoma (listed in the Statistical Analysis section
below) and other lifestyle factors that might confound the vitamin
D-melanoma association. Body mass index (kg/m2) was computed
from self-reported weight at baseline and height when participants
were tallest. Total physical activity, in MET-hours/week, was
calculated from all reported regular activity in the past 10 years
(Littman et al., 2004).
Melanoma ascertainment
Incident melanoma cases were identified though annual linkage of the
VITAL cohort database to the SEER cancer registry. For each tumor, we
abstracted information about location (head and neck versus other),
tumor subtype (lentigo maligna versus superficial spreading versus
other), and Breslow depth. We used the tumor location and subtype as
proxies for sun exposure history (chronic versus intermittent). We used
Breslow depth as a proxy for tumor progression.
Statistical analysis
Cox proportional hazards models were used to estimate age- and
multivariate-adjusted RR and 95% CIs for vitamin D intake and
melanoma risk. Age was treated as the time variable with
participants entering at their baseline age and exiting at their age
at diagnosis of melanoma (event) or censor date. Censor date was
defined as the earliest date of: withdrawal from the study (0.03%);
date of death (4.6% as ascertained from Washington State death
files); date moved out from the 13 county catchment area of the SEER
registry (5.4% as identified by linkage to the National Change of
Address System and other follow-up procedures); or the end of
follow-up on December 31, 2006.
For our multivariable models, we adjusted for suspected or
established risk factors for melanoma, including age at baseline (years),
gender (female, male), education (high school or less, some college,
advanced degree), first degree family history melanoma (no, yes),
personal history of nonmelanoma skin cancer (no, yes), ever had moles
removed (no, yes), freckles between ages 10 and 20 years (no, yes), had
X3 severe sunburns between ages 10 and 20 years (no, yes), natural
red/blond hair between ages 10 and 20 years (no, yes), and reaction to
1-hour in strong sunlight (tan or no sunburn, mild burning, painful
sunburn, severe sunburn with blistering). Analyses of dietary vitamin D
were adjusted for total energy intake (kcal/day). Participants were
excluded from the dietary and total (diet plus supplement) nutrient
analyses if they did not complete all pages of the food frequency
questionnaire or if their reported total energy intake was o600 or
44,000kcal for women or o800 or 45,000kcal for men. Statistical
tests were two sided. All statistical analyses were performed using SAS,
version 9.1 (SAS Institute Inc., Cary, NC).
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